Overview

• Axon’s Q2 revenue rose 33% year over year to $668.5 million, topping the $631.6 million LSEG estimate, while adjusted EPS reached $2.12 against a $1.46 consensus.
• The company increased its full-year 2025 revenue outlook to $2.65 billion–$2.73 billion from $2.60 billion–$2.70 billion, marking its third consecutive guidance raise this year.
• All major divisions posted double-digit growth as TASER sales climbed 19%, software and services revenue jumped 39% and platform solutions revenue reached $67 million.
• Shares rallied about 14% on the news, with Raymond James, UBS and Needham subsequently lifting their price targets.
• Accelerating demand for subscription-based body cameras and security technologies has driven Axon’s stock to more than double since late 2024.